Correction to: Use of MFM-20 to monitor SMA types 1 and 2 patients treated with nusinersen

Neurol Sci. 2023 Mar;44(3):1139. doi: 10.1007/s10072-022-06522-w.
No abstract available

Publication types

  • Published Erratum